期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
胸腔镜经二尖瓣室间隔心肌切除术治疗左心室中部梗阻的肥厚型心肌病的早期效果 被引量:4
1
作者 魏培坚 刘健 +3 位作者 谭桐 朱伟 庄建 郭惠明 《中华外科杂志》 CAS CSCD 北大核心 2023年第3期214-219,共6页
目的探讨胸腔镜经二尖瓣室间隔心肌切除术治疗左心室中部梗阻的肥厚型心肌病的早期手术效果。方法回顾性收集2020年4月至2021年7月在广东省人民医院心外科接受胸腔镜经二尖瓣室间隔心肌切除术治疗的10例左心室中部梗阻的肥厚型心肌病患... 目的探讨胸腔镜经二尖瓣室间隔心肌切除术治疗左心室中部梗阻的肥厚型心肌病的早期手术效果。方法回顾性收集2020年4月至2021年7月在广东省人民医院心外科接受胸腔镜经二尖瓣室间隔心肌切除术治疗的10例左心室中部梗阻的肥厚型心肌病患者的临床资料,男性7例,女性3例,年龄(52.0±16.4)岁(范围:18~68岁),欧洲心血管手术危险因素评分系统Ⅱ预测手术病死率[M(IQR)]为1.78%(1.20%)(范围:0.96%~4.86%)。采用配对t检验、配对Wilcoxon检验或Fisher确切概率法比较手术前后左心室流出道峰值压差、室间隔最大厚度、二尖瓣前叶收缩期前向运动等超声心动图指标,记录围手术期和随访期间的并发症发生情况。结果全组患者均成功完成手术,无中转正中开胸、无室间隔穿孔或心脏破裂。全组患者无围手术期死亡,未发生永久性起搏器植入、再次开胸止血、低心排血量综合征、卒中和多器官功能障碍综合征等严重并发症。与术前相比,术后室间隔厚度减小[(10.3±1.7)mm比(22.1±4.0)mm,t=-10.693,P<0.01],左心室流出道压差峰值降低[12.3(11.5)mmHg比(81.7±21.1)mmHg,Z=-2.805,P<0.01;1 mmHg=0.133 kPa],有效解除了左心室流出道梗阻。结论胸腔镜经二尖瓣室间隔心肌切除术治疗左心室中部梗阻的肥厚型心肌病可获得较好的早期效果。 展开更多
关键词 心肌病 肥厚性 胸腔镜检查 经二尖瓣 心肌切除术 左心室中部梗阻
原文传递
CHANGES OF PLASMA DYNORPHIN LEVELS BEFORE AND AFTER PERCUTANEOUS BALLOON MITRAL COMMISSUROTOMY IN PATIENTS WITH MITRAL STENOSIS
2
作者 尹瑞兴 陶新智 +3 位作者 曾知恒 赵定菁 朱树雄 夏树楹 《Chinese Medical Sciences Journal》 CAS CSCD 1995年第4期214-219,共6页
Plasma dynorphin A1-13 levels were measured in 33 patients with mitral stenosis before and after percutaneous balloon mitral commissurotomy (PBMC). The results show that the basal levels of plasma dynorphin in blood f... Plasma dynorphin A1-13 levels were measured in 33 patients with mitral stenosis before and after percutaneous balloon mitral commissurotomy (PBMC). The results show that the basal levels of plasma dynorphin in blood from the antecubital vein in the patients were significantly higher than those in 31 healthy control subjects. The increase in circulating dynorphin closely correlated with the functional cardiac status and the presence of atrial fibrillation. Ten to fifteen minutes after PBMC, plasma dynorphin levels in blood from the femoral vein increased significantly. Seventy-two hours after the procedure, the levels of plasma dynorphin in blood from the antecubital vein had decreased significantly , but they did not decrease to the normal range. Plasma dynorphin levels in blood from the femoral vein were positively correlated with the mean left atrial pressure and the mean right atrial pressure before the first balloon inflation. Plasma dynorphin levels in blood from the antecubital vein were positively correlated with the heart rate and the mean transmitral pressure gradient, and negatively with the mitral valve area before and 72 hours after PBMC. 展开更多
关键词 mitral stenosis percutaneous balloon mitral commissurotomy DYNORPHIN
下载PDF
Assessment of mitral valve reserve capacity before and after percutaneous balloon valvuloplasty with isoproterenol stress echocardiography
3
作者 刘品明 傅向阳 +2 位作者 吕俊豪 吴群 杨福庆 《Journal of Medical Colleges of PLA(China)》 CAS 2002年第3期196-201,共6页
Objective: To explore whether successful valvuloplasty increases mitral valve reserve capacity in patients with mitral stenosis. Methods: Thirty-eight patients with pure rheumatic mitral stenosis underwent isoproteren... Objective: To explore whether successful valvuloplasty increases mitral valve reserve capacity in patients with mitral stenosis. Methods: Thirty-eight patients with pure rheumatic mitral stenosis underwent isoproterenol stress echocardiography before and after successful percutaneous balloon valvuloplasty. The mitral valve area (by direct planimetry of two-dimensional echocardiography), mean transmitral pressure gradient (by continuous-wave Doppler echocardiography), and cardiac output (by M-mode echocardiography) were measured at rest and under isoproterenol infusion to achieve heart rate of different stages. Results:Between the measurements before and after valvuloplasty, significant differences were observed in the mitral valve area (0. 91±0. 28 vs 1. 87±0. 23 cm2, P<0. 01), mean transmitral pressure gradient (12. 5±6. 3 vs 3. 9±1. 9 mmHg, P<0. 01) and cardiac output (3. 93±1. 44 vs 4. 73±1. 01 L/min, P<0. 05) at rest. Before valvuloplasty, the mean transmitral pressure gradient increased significantly (P<0. 01) as heart rate increased, but there were no significant differences in the measurements of mitral valve area and cardiac output (both P>0. 05). In contrast, there was a significant increase after valvuloplasty in the mean transmitral pressure gradient (P<0. 01), but both mitral valve area and cardiac output further increased (both P< 0. 01) as heart rate increased. Moreover, valvuloplasty decreased the mean transmitral pressure gradient at peak heart rate from 23. 0±4. 5 to 7. 75±2. 30 mmHg (F<0. 01) under submaximal stress. Conclusion: Successful percutaneous balloon valvuloplasty soon causes a significant increase of mitral valve reserve capacity in patients with mitral stenosis, which is conspicuously manifested under condition of hemodynamic stress. Stress echocardiography provides a safe, feasible and non-invasive means of assessing the reserve capacity. 展开更多
关键词 mitral valve stenosis balloon dilation HEMODYNAMICS ECHOCARDIOGRAPHY ISOPROTERENOL
下载PDF
MITRAL VALVE PAPILLARY FIBROELASTOMA:CASE REPORT
4
作者 黄英 蒋米尔 Yves GLOCK 《Journal of Shanghai Second Medical University(Foreign Language Edition)》 2003年第2期129-131,共3页
Objective To evaluate the transesophageal echocardiography(TEE) and surgical treatment to cardiac papillary fibroelastomas (CPFE). Methods CPFE is a rare benign tumor occuring mainly in valves and often revealed by se... Objective To evaluate the transesophageal echocardiography(TEE) and surgical treatment to cardiac papillary fibroelastomas (CPFE). Methods CPFE is a rare benign tumor occuring mainly in valves and often revealed by serious cerebral, coronary and peripheral embolism or even sudden death. We report a case of mitral PFE diagnosed by transesophageal echocardiography (TEE), and surgical resection was performed. Results Surgical intervention is successful, and the follow-up courses are uneventful. Conclusion TEE is helpful to diagnosis and guiding the operation. Operation is recommended to prevent recurrent embolization complications. 展开更多
关键词 mitral valve fibroelastoma transesophageal echocardiography surgical treatment
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部